Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 14, 2023; 29(6): 908-916
Published online Feb 14, 2023. doi: 10.3748/wjg.v29.i6.908
Published online Feb 14, 2023. doi: 10.3748/wjg.v29.i6.908
Figure 1 Potential mediators of liver damage associated to coronavirus disease 2019, fatty liver, and obesity.
ACE2: Angiotensin converting enzyme 2; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2. Parts of the figure were drawn by using pictures from Servier Medical Art (smart.servier.com).
- Citation: Lempesis IG, Karlafti E, Papalexis P, Fotakopoulos G, Tarantinos K, Lekakis V, Papadakos SP, Cholongitas E, Georgakopoulou VE. COVID-19 and liver injury in individuals with obesity. World J Gastroenterol 2023; 29(6): 908-916
- URL: https://www.wjgnet.com/1007-9327/full/v29/i6/908.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i6.908